Lectures 13 & 14 - Monoclonal antibodies, cancer immunotherapy and molecular imaging Flashcards
Describe a polyclonal response to antigens
Injection with a single antigen will produce a complex mixture of antibodies, each made by a different clone of B cells
What are monoclonal antibodies?
Antibodies that bind to epitopes specific to individual antigens
What are the two features on the outside of malignant cells you can look for to target in the production of MABs?
Epitopes unique to the malignant or faulty cell
Conserved antigens that are present both on healthy and malignant cells, but in the malignant cell the epitope has a mutation
What did the work of George Kohler and Cesar Milstein achieve between 1975 and 1984?
The development of hybridoma technology to produce monoclonal antibodies
How are hybridoma cells produced?
A single clone of cells secreting a single
antibody is made by fusing a B cell (Ig+ splenocyte
with finite lifespan) with a myeloma cell (cancerous
Ig- B cell with infinite lifespan).
This results in hybrid cells (hybridomas) that are both immortal and produce a specific monoclonal AB
How are MABs produced in hybridomas lab?
- Immunise mouse injecting into peritoneum
- Antigen goes into blood stream and activates b cells within spleen and lymphatics
- Activation of low affinity pentameric IgM
- Booster injections given over time every 2 weeks
Switching from multivalent IgM to bivalent IgG - Aim to get IgG as downstream these are the easiest to work with in terms of therapy and diagnostics
- Test serum from tail vein bleed for response to target antigen
- If its responded give booster injection and then euthanise mouse and remove mouse spleen and make hybrid cells
How are hybridomas produced in lab?
- Immunise mouse or rabbit with antigen of choice
- Remove the spleen from the immunised animal to gather B cells secreting antigen specific ABs
- Screen myeloma cells from culture for those that are unable to make antibody and cannot survive in HAT medium
- Fuse splenocytic b cells and myeloma cells to produce hybridoma
- Transfer cells to HAT medium, where unfocused B cells will die naturally and immortal hybridomas will survive
- Screen remaining cells for specific antibody producing clones, isolating these
- Grow the single clone in tissue culture medium, these cells will produce monoclonal antibodies against antigen
How does selection of cells through the use of HAT media work?
Aminopterin blocks the main biosynthetic pathways for nucleic acid, so stops production of RNA and DNA
Within the cells there is a salvage pathway and this relies on 2 enzymes – thymidine kinase and HGPRT
If you give exogenous H and T in the HAT medium, they can salvage nucleic acid biosynthesis
Both cell types have thymidine kinase so can make DNA but only those with the HGPRT gene can make RNA through the salvage pathway
Splenocytes are HGPRT+ but aren’t able to grow in long term culture
Myeloma cells are HGPRT- therefore aren’t able to grow in HAT medium
Hybredoma cells has HGPRT+ gene from splenocyte and immortality from myeloma so can grow in both HAT medium and long term culture
Exposing the cells to HAT medium in long term culture ensures only the hybredoma cells survive
Which assay is used to identify the well containing the clone which produces the AB of interest?
ELISA
What is phage display?
A technique in which peptides or proteins (e.g.
antibody fragments) are expressed as a fusion
with a coat protein of a bacteriophage
How are phages made?
Take B cell source and make combinatorial library:
1. Source can be an immunised b cell source/ naïve animal/ human b cells
- Take mRNA from these cells and turn into complementary dna
- Amplify v gene family using PCR. This will amplify variable heavy and light chains encoded within the complementary DNA
- Reassemble to make combinations of vl and vh that may not even be in the animal in the first place
- Put into phage which then expresses this info on cell surface as AB fragments
How can phage display be used to produce MABs?
Many phages are produced with different gene combinations for Vh and Vl genes (these determine the heavy and light chain fragments of the antibody)
Each phage will therefore produce different subsets of antibodies, which by use of an ELSIA can be screened for their ability to bind the specific antigen of interest.
The population of phages producing the specific MAB we are interested in is gradually enriched by challenge and washing of those that don’t bind. (Biopanning)
What are the steps in the process of phage selection?
- Build a phage antibody library
- Biopanning and washing to remove phages that don’t bind strongly to antigen
- Shadow stick selection uses UV light to destroy phages that aren’t required
- Reinfection of phages with e.coli in order to bulk up phage production of antibody of interest.
What are the widespread applications of MABs in science and diagnostic medicine?
Diagnostic pathology (cytology and histology) In vitro diagnostic assays based on ELISA/ lateral flow/ proximity ligation assays for pathogens and biomarkers of disease Affinity purification and characterisation of antigens
Why do MABs need to be humanised?
- Immunogenicity - Most MABs are of mouse origin and are therefore xenogeneic, resulting in HAMA relations, causing their rejection and consequential destruction
- Origin - Their mouse origin diminishes their ability to elicit effector mechanisms such as complement mediated lysis or ADCC
What strategies have been adopted in order to humanise xenoantibodies?
- Production of human hybridomas from human B lymphocytes, this however has very low efficiency and there are some ethical issues surrounding it
- Replacement of the constant regions of mouse mAbs with those of human antibodies yielding chimeric ABs - this leaves the important heavy and light chain of Fab fragment, this however will still be recognised by the human immune system as foreign eventually and rejected.
- Replacement of the complementarity determining regions (CDRs) of a human antibody with those of a mouse antibody via CDR grafting to make a humanised antibody
- Production of fully humanised mAbs in transgenic mice - this involves taking a mouse and knocking out their entire genetic mechanism to make human abs in mice and don’t express any mouse ab
What are chimeric antibodies?
Antibodies that are engineered to contain both mouse and human regions.
The variable heavy and light chains on the human antibody are replaced with that of a mouse, so these regions can bind specifically to the antigen of interest.
The fixed regions of the human AB remain and these are able to mediate ADCC and CDC which a mouse AB would be unable to do alone.
What is CDR grafting?
Replacement of the hyper variable loops within the CDRs (variable heavy and light chains) in a human AB with that of a mouse, in order to increase their binding specificity